Nodal Signaling as a Developmental Therapeutics Target in Oncology

Area of Science:

• Oncology
• Developmental Biology
• Molecular Biology

Background:

• The tumor microenvironment plays a critical role in cancer development and progression.
• Cancer cells share similarities with early developmental stem cells, including plasticity and signaling pathways.
• Nodal signaling is essential for fetal development and is re-expressed in epithelial cancers.

Purpose of the Study:

• To investigate the role of Nodal signaling in epithelial cancers.
• To explore the potential of targeting the Nodal pathway as a novel cancer therapy.

Main Methods:

• Analysis of Nodal expression in breast and melanoma cancer tissues.
• Investigation of the Nodal signaling cascade involving Cripto-1, Smad2/Smad3, and Lefty.
• Evaluation of Nodal pathway inhibition as a therapeutic strategy.

Main Results:

• High Nodal expression correlates with aggressive tumor grades in breast and melanoma.
• Cancer cells exhibit uncontrolled Nodal signaling due to a lack of its inhibitor, Lefty.
• The Nodal-Cripto-1 interaction activates Smad2/Smad3, promoting downstream gene expression.

Conclusions:

• Reactivation of the Nodal pathway in cancer contributes to tumor progression.
• The absence of Lefty in cancer cells leads to dysregulated Nodal signaling and uncontrolled growth.
• Inhibiting the Nodal pathway represents a promising new therapeutic target for oncology.